This lack of correlation may be evidence that ORAI3 is not a driver of cell migration in basal breast cancers, but rather is a fine-tuner of cancer cell migration in some in vivo contexts, through changing the suite of expressed genes in response to specific microenvironmental factors. The gene discussed is ORAI3; the disease is cancer.